Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 51655-311

4 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 51655-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (4035482a 7e09 464f Ae01 A8a75fc3c4c1 01)

Figure 1 (4035482a 7e09 464f Ae01 A8a75fc3c4c1 01)
Chemical structure diagram of lisinopril dihydrate, an active ingredient in the Lisinopril and Hydrochlorothiazide oral tablet by Northwind Health Company, LLC.*
FDA Label Image

Figure 2 (4035482a 7e09 464f Ae01 A8a75fc3c4c1 02)

Figure 2 (4035482a 7e09 464f Ae01 A8a75fc3c4c1 02)
Chemical structure diagram showing the molecular formula of an active ingredient associated with Lisinopril and Hydrochlorothiazide tablets. The chemical structure includes a chlorinated benzene ring and sulfonamide functional groups, representing one of the components in the combination drug.*
FDA Label Image

Image (4035482a 7e09 464f Ae01 A8a75fc3c4c1 145 1)

Image (4035482a 7e09 464f Ae01 A8a75fc3c4c1 145 1)
Lisinopril and Hydrochlorothiazide tablets packaging label showing the proprietary and generic name, dosage form as oral tablets, and strength of 20 mg / 12.5 mg. The label includes the Northwind Health Company, LLC as the labeler. The package design features black text on a white background with a distinctive black cross-like symbol.*
FDA Label Image

Label (51655 311 26 Rev A 09 22 Nhc)

Label (51655 311 26   Rev A 09 22 Nhc)
Label for Lisinopril and Hydrochlorothiazide tablets, USP 20 mg/12.5 mg, oral dosage form. The label indicates 90 tablets per container, prescription use only, and storage instructions at controlled room temperature. It includes the NDC 51655-311-26 and is labeled by Northwind Health Company, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.